Interstitial Cystitis

Detailed Overview

IC/BPS is a debilitating condition that severely impacts quality of life. The exact etiology is unknown but involves an altered bladder mucosal lining (defective glycosaminoglycan layer), neurogenic inflammation, and mast cell activation. Diagnosis is largely clinical after ruling out UTI, overactive bladder, and malignancy.

Epidemiology & Demographics

Prevalence is estimated at 3 to 8 million women and 1 to 4 million men in the US. Female-to-male ratio is roughly 5:1. Typical age of onset is over 40 years.

Etiological Mechanism

Unknown. Theories include urothelial dysfunction (leaky epithelium), autoimmunity, neurogenic inflammation, and occult infection.

Primary Causes

Epithelial dysfunction (loss of protective GAG layer)

Mast cell activation in bladder wall

Neurogenic upregulation/sensitization

Autoimmune response

• Female Sex: Significantly higher prevalence in women.
• Other chronic pain syndromes: Highly associated with fibromyalgia, IBS, and endometriosis.
• Pelvic trauma or surgery: Can trigger the onset of chronic pelvic pain.

The leading theory involves a defect in the protective glycosaminoglycan (GAG) layer of the urothelium. This 'leak' allows urinary solutes, notably potassium, to penetrate the submucosa and directly stimulate sensory C-fibers. This causes severe pain and triggers localized neurogenic inflammation, including mast cell degranulation (releasing histamine) and further mucosal injury. Over time, central sensitization of the nervous system leads to chronic neuropathic pain.

Characteristic Clinical Presentation

• Bladder Pain: Suprapubic, pelvic, or perineal pain that worsens as the bladder fills and is temporarily relieved by voiding.
• Urinary Frequency: Urinating up to 60 times a day in severe cases.
• Urinary Urgency: A compelling need to urinate, driven by pain rather than fear of leakage (as in OAB).
• Dyspareunia: Pain during sexual intercourse.

Physical Examination Signs

• Suprapubic tenderness on palpation
• Tenderness of the anterior vaginal wall/bladder base on bimanual pelvic exam
• Absence of neurological deficits
• Normal prostate exam in men (differentiating from prostatitis)

• Reduced Bladder Capacity: Fibrosis and scarring lead to a rigid, small bladder.
• Severe Depression and Anxiety: Due to chronic pain, severe sleep deprivation from nocturia, and poor quality of life.
• Sexual dysfunction: Avoidance of intimacy due to dyspareunia.

Diagnostic Criteria & Guidelines

Pelvic pain, pressure, or discomfort related to the bladder for at least 6 weeks, accompanied by at least one lower urinary tract symptom (urgency/frequency), in the absence of infection or other identifiable causes.

Differential Diagnosis

• Urinary Tract Infection (UTI)
• Overactive Bladder (OAB)
• Bladder Cancer (Carcinoma in situ)
• Endometriosis

Laboratory Tests & Biomarkers

• Urinalysis: Typically normal. May show microhematuria. Leukocyte esterase and nitrites are negative.
• Urine Culture: Negative (sterile urine rules out bacterial UTI).
• Urine Cytology: Negative (performed to rule out high-grade bladder cancer, especially in smokers with hematuria).

Imaging Modalities & Findings

• Cystoscopy with hydrodistension: Used primarily if Hunner's lesions are suspected or to rule out cancer. May reveal glomerulations (petechial hemorrhages) after bladder stretching, or classical Hunner's lesions.

• Non-ulcerative
  Normal mucosa or glomerulations (pinpoint hemorrhages) on cystoscopy. Most common (90%).
• Ulcerative (Hunner's lesions)
  Presence of red, bleeding patches (Hunner's ulcers) on the bladder wall. More severe symptoms (10%).

Second-Line & Adjunctive Therapy

Intravesical instillation therapies: Dimethyl sulfoxide (DMSO), Heparin, or Lidocaine solutions instilled directly into the bladder via catheter. For Hunner's lesions: Cystoscopic fulguration (laser or electrocautery) or triamcinolone injection.

Surgical & Procedural Management

Sacral neuromodulation (InterStim) for refractory frequency. In end-stage disease with contracted bladder and intractable pain, cystectomy with urinary diversion (ileal conduit) is a last resort.

Recommended Lifestyle Changes

• Adopt an IC elimination diet: strictly avoid coffee, tea, alcohol, carbonated drinks, citrus, tomatoes, and spicy foods.
• Pelvic floor physical therapy (internal myofascial release). Avoid Kegel exercises as they can worsen pelvic floor spasm.
• Bladder training and timed voiding techniques.

Patient Counseling & Advice

Set realistic expectations: there is no cure for IC/BPS, and treatment is focused on symptom control. Stress the importance of dietary triggers, as diet plays a massive role in flares.

Follow-Up & Monitoring Schedule

Regular follow-up to assess symptom scores (e.g., O'Leary-Sant Symptom Index). Patients on Pentosan polysulfate (Elmiron) require annual ophthalmologic exams due to the risk of pigmentary maculopathy.

Preventive Strategies

No known preventive measures, but recognizing and avoiding personal dietary triggers prevents acute flares.

Highly variable. Some patients experience spontaneous remission, while others have a chronic relapsing-remitting course requiring lifelong multimodal therapy.